Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice

Diabetes

Volumn 49, Issue 12, 2000, Pages 1998-2006

  Fujihira, Kazuhiro ^a   Nagata, Masao ^a   Moriyama, Hiroaki ^a   Yasuda, Hisafumi ^a,b   Arisawa, Kenji ^a   Nakayama, Maki ^a   Maeda, Sakan ^a   Kasuga, Masato ^a   Okumura, Ko ^b   Yagita, Hideo ^a,b   Yokono, Koichi ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; MONOCLONAL ANTIBODY;

ADOLESCENT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE COURSE; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; INSULITIS; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TH1 CELL;

EID: 0033674426     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.12.1998     Document Type: Article

References (55)

1. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
2. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases
3. Determination of islet cell antibodies by immunofluorescence
4. Molecular cloning and identification of a relation-type protein tyrosine phosphatase, IA- 2 from human insulinoma
5. Insulin antibodies in insulin-dependent diabetics before insulin treatment
6. T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type I diabetes
7. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes
8. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes
9. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: Therapeutic intervention by immunostimulation?
10. + islet-specific T cell clone
11. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
12. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice
13. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse
14. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice
15. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma
16. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice
17. Function diversity of helper lymphocytes
18. + T cells to enhance priming for interferon-γ production and diminishes interleukin 4 inhibition of such priming
19. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
20. 2
21. Deviation of pancreasinfiltrating cells to Th2 by interleukin- 12 antagonist administration inhibits autoimmune diabetes
22. Interleukin- 12 administration induces T helper type 1 cells and accelerates autoimmune disease in NOD mice
23. Local expression of immunoregulatory IL-12p40 gene prolonged syngenic islet graft survival in diabetic NOD mice
24. Mapping antigenic and functional epitopes on the α- and β-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and MAC-1
25. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapse of experimental autoimmune encephalomyelitis
26. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones: Differential requirement for CD8 T-cells
27. T helper cell subsets in insulin-dependent diabetes
28. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice
29. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice
30. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in nonobese diabetic mice
31. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse
32. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): Similarities between TNF-alpha and interleukin 1
33. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice
34. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha
35. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen1/intercellular adhesion molecule-1 pathway
36. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice
37. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning
38. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice
39. Immunostimulation circumvents diabetes in NOD/Lt mice
40. - T-cell deficiency and IDDM in NOD/Lt mice
41. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
42. Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice
43. + T cells
44. Interleukin-2 receptor chanin regulates the size and content of the peripheral lymphoid compartment
45. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta
46. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis
47. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice
48. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice
49. Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease
50. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice
51. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice
52. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin- 2 gene
53. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x
54. Suppression of concanavalin A-induced responses in splenic lymphocytes by activated macrophages in the non-obese diabetic mouse
55. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice